MULTİPLE SKLEROZ VE YÜRÜYÜŞ

Yürüyüş bozukluğu, Multiple Skleroz’lu (MS) hastalarda en sık rastlanan ve özüre neden olan problemlerden biridir. Hastaların %75-85’i esas problem olarak yürüyüş bozukluğunu bildirmişlerdir. Hastalık sonucunda gelişen spastisite, koordinasyon bozuklukları, zayıflık ve vestibular problemler gibi yetersizlikler, hastalarda tipik olarak daha kısa bir adım uzunluğunda ve artmış çift destek fazında yürüyüşe neden olabilmektedir. MS’li hastalarda görülen yorgunluk; yürüyüş parametreleri, mesafesi ve yürüyüş süresini olumsuz yönde etkileyebilmektedir. Son yıllarda MS gibi hareket kısıtlılığı olan pek çok hastalıkta, yürüyüşe yönelik fonksiyonel değişiklikleri objektif olarak değerlendiren bilgisayarlı yürüme analizi sistemlerinin kullanımının önem kazandığı görülmektedir. Bu analizler sonucunda elde edilen verilerin, tedavi programının belirlenmesi ve uygun cihaz seçimi konusunda sağlık ekibine objektif bilgiler sağladığı düşünülmektedir

Anahtar Kelimeler:

Multiple Sklerozis, Yürüyüş

Gait disorders are one of the most commons problems that cause disability in multiple sclerosis (MS) patients. About 75-85% of the patients reported gait disorder as their main problem. Disorders such as spasticity, coordination problems, vestibular problems, weaknesses and deficiencies, which are the results of disease, cause patients typically have a shorter stride length and increased double-support phase in walking. Fatigue could adversely affect the gait parameters, and distance duration of walking in MS patients. In the recent years, in many diseases such as MS, evaluation of the limitation of movement and functional changes objectively by a computerized gait analysis system gained considerable importance. It is believed that, data obtained from gait analysis provide objective information to the health care team on determining the treatment program and the appropriate device selection

Keywords:

Multiple Sclerosis, Gait Disorders,

PDF

___

World Health Organization (WHO). 2001. International Classification of Functioning, Disability and Health (ICF). Geneva, Switzerland.
Salter K, Jutai JW, Teasell R, Foley NC ve ark. Issues for selection of outcome measures in stroke rehabilitation: ICF Participation. Disability and Rehabilitation. 2005; 27(9):507-528.
Richards RG, Sampson FC, Beard SM ve ark. A review of the natural history and epidemiology of multiple sclerosis: implications for resources allocation and health economic models. Health Technology Assessment. 2002; 6: 10.
The Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis: part II: quality of Life. The Canadian Journal of Neurological Sciences. 1998; 25: 31-38.
Brown M, Gordon WA. Participation in social and recreational activity in the community by individuals with traumatic brain injury. Rehabilitation Psychology. 2003;48(4): 266-274.
Cicerone KD, Mott T, Azulay J, Friel JC. Community integration and satisfaction with functioning after intensive cognitive rehabilitation for traumatic brain injury. Archives of Physical Medicine and Rehabilitation. 2004; 85(4): 943-950.
Dijkers M. Measuring the long-term outcome of traumatic brain injury: A review of the Community Integration Questionnaire. The Journal of Head Trauma Rehabilitation 1997;126: 74-91.
Goldman MD, Cohen JA, Fox RJ, Bethoux FA. Multiple sclerosis: Treating symptoms, and other general medical issues. Cleveland Clinic Journal of Medicine 2006;73(2): 177-186.
Umphred DA. Neurological Rehabilitation, Mosby Harcourt Sciences Company, U.S.A. 4. Baskı 2001; 595- 615.
O’Connor P. Key Issues In The Diagnosis and Treatment of Multiple Sclerosis: An Overview, Neurology, 2002;59(3): 1-32.
Noseworthy JH, Lucchinetti C, Rodriguez M ve ark. Multiple Sclerosis, Medical Progress. 2000; 28: 938- 952.
Gilroy J, (Çev. Editörü: Karabudak R.), Temel Nöroloji, Günes Kitabevi, 3, Baskı, 199-224, 2002.
Freeman J, Morris M, Davidsoson M ve ark. Outcome measures to quantify the effects of physical therapy for people with multiple sclerosis. Neurology. Report 2002;26(3): 139-144.
Hoogervorst EL, Kalkers NF, Uitdehaag BM, Polman CH. A study validating changes in the multiple sclerosis functional composite. Arch Neurol. 2002;59(1): 113-6.
Verdier-Taillefer MH, Roullet E, Cesaro P, Alperovitch A. Validation of self-reported neurological disability in multiple sclerosis. Int J Epidemiol. 1994;23(1): 148-54.
Hoogervorst EL, Eikelenboom MJ, Uitdehaag BM ve ark. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J. Neurol. Neurosurg. Psychiatry. 2003;74: 439-42.
Myhr KM, Riise T, Vedeler C ve ark. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension” , Mult. Scler. 2001;7: 59-65.
Morris ME, Cantwell C, Vowels L ve ark. Changes in gait and fatigue from morning to afternoon in people with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 2002; 72: 361-5.
Ringel I, Zettl U.K. Estimates of the walking distance in multiple sclerosis patients and their effect on the EDSS. J. Neurol. 2006;253: 666-7.
Umphered D.A. Neurological Rehabilitation, fourth edition, chapter 20, Multiple sclerosis, 595-615. Mosby company, London, 2001:79
Frzovic D, Morris M.E, Vowels L. Clinical tests of standing balance: performance of persons with multiple sclerosis. Arch. Phys. Med. Rehabil. 2000; 81: 215-21.
Stuifbergen AK, Blozis SA, Harrison TC ve ark. Exercise, functional limitations, and quality of life: A longitudinal study of persons with multiple sclerosis. Arch. Phys. Med. Rehabil. 2006;87: 935-43.
Swingler R, Compston D.A.S. The morbidity of multiple sclerosis. Q. J. Med.1992; 83: 325-337.
Benedetti M.G., Piperno R., Simoncini L. ve ark. Gait abnormalities in minimally impaired multiple sclerosis patients. Mult. Scler. 1999;5: 363-8.
Syndulko K, Ke D, Ellison GW ve ark. Comparative evaluations of neuroperformance and clinical outcame assessments in chronic progresivve multiple sclerosis: I. Reliability , validity and sensivity to disease progression. Multiple Sclerosis Study Group. Mult Scler. 1996;2: 142-156.
Gehlsen GM, Grigsby SA, Winant DM. Effects of an aquatic fitness program on the muscular strength and endurance of patients with multiple sclerosis. Phys Ther. 1984;64: 653-657.
King DL, Rodgers MM, Ponichtera –Mulcare JA. Disease severity in multiple sclerosis and its effect on gait. Gait Posture. 1994;2(1):60.
Holden MK, Gill KM, Magliozzi MR ve ark. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther. 1984;64: 35-40.
Kelleher K, Spence W, Solomoidins S. The characterisation of people with multiple sclerosis. Disability and Rehabilitation. 2010;32(15): 1242-1250.
Keser İ. Multiple Sklerozda Kalistenik Egzersizler. H.Ü, Sağlık Bilimleri Enstitüsü, Bilim Uzmanlığı Tezi. Ankara, 2003.